AUROPHARMA Outlook for the Week - Equitypandit
3 days ago • Google News
Aurobindo Pharma Limited (AUROPHARMA)
NSEINR 1100.10.52%
Price Chart
Key Statistics
Market Cap
INR 635.63B
P/E Ratio
18.76
Revenue (TTM)
INR 320.25B
Volume
1.37M
52W High
INR 1578.03
52W Low
INR 1006.22
Dividend Yield
0.00%
Beta
0.14
Technicals
50-Day MA
1089.284
200-Day MA
1151.9583
52 Week High
1578.0292
52 Week Low
1006.2247
About AUROPHARMA
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company.
Employees
27707
Headquarters
Hyderabad, India
CEO
Mr. Kambam Nithyananda Reddy
Latest News
Aurobindo Pharma shares fall post Q4; Should you buy, sell or hold? - TradingView
2025-05-27 • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
38.43
Percentile: 81.1
Environmental Risk Score
3.81
Percentile: 2
Social Risk Score
21.42
Percentile: 2
Governance Risk Score
16.2
Percentile: 2
Controversy Level
ESG data provided by Sustainalytics, Inc.
AUROPHARMA
Category Average
3Significant Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg